Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Neoplasms × Lapatinib × Clear all

Phase

Status

Completed 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 10 Oesophagogastric Cancer 1 Neoplasms 1 Neoplasm Metastasis 1 Invasive Breast Cancer 1 HER2-positive Advanced Breast Cancer 1 HER2 Positive Metastatic Breast Cancer 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Diseases 1

Interventions

Fluorouracil 68 Oxaliplatin 62 Leucovorin 53 Irinotecan 53 Capecitabine 51 Bevacizumab 51 Cetuximab 41 Folfox protocol 20 Drug Therapy 20 Neoadjuvant Therapy 18 HMPL-013 15 regorafenib 13 Colonoscopy 13 apatinib 11 XELOX 10 Chemotherapy, Adjuvant 10 raltitrexed 9 Radiotherapy 9 trifluridine tipiracil drug combination 8 sintilimab 8 Surveys and Questionnaires 8 Surgical Procedures, Operative 8 Panitumumab 8 IFL protocol 8 Blood Specimen Collection 8 tislelizumab 7 Laparoscopy 7 Endoscopic Mucosal Resection 7 Aspirin 7 Trastuzumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03225937 2018-10-30

HERACLES

Fondazione del Piemonte per l'Oncologia

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡